Studies have also shown that PRMT5 promotes Warburg anaerobic glycolysis in human breast and pancreatic cancer cells [18, 19], and PRMT5 knockdown also reduces glucose consumption or the extracellular acidification rate (ECAR) [20]. The gene discussed is PRMT5; the disease is pancreatic neoplasm.